Nanosonics Limited (FRA:OQS)
Germany flag Germany · Delayed Price · Currency is EUR
2.360
+0.040 (1.72%)
At close: Nov 28, 2025

Nanosonics Company Description

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific.

The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies.

It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform.

Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Nanosonics Limited
CountryAustralia
Founded2000
IndustryElectromedical and Electrotherapeutic Apparatus
Employees470
CEOMichael Kavanagh

Contact Details

Address:
Building A
Macquarie Park, 2113
Australia
Phone61 2 8063 1600
Websitenanosonics.com.au

Stock Details

Ticker SymbolOQS
ExchangeFrankfurt Stock Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
SIC Code3845

Key Executives

NamePosition
Michael KavanaghChief Executive Officer
Jason BurrissChief Financial Officer
Rod LopezChief Operating Officer